Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Beluga Health vs Elevate Health

Beluga Health
Graded #430

Lower grade

vs+2.700000000000003
Elevate Health
Graded #371

Higher grade

The verdict

Elevate Health takes it — 58.5/100 to 55.8/100.

Elevate Health grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Elevate Health (Elevate Health and Wellness) is a medical weight-loss telehealth service offering compounded semaglutide (from $299/mo, or $158/mo on a 12-month plan) and compounded tirzepatide GLP/GIP…

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueBeluga Health +13
45
32
Dose & formulationElevate Health +37
40
77
Clinical oversightElevate Health +3
76
79
Labs & monitoringElevate Health +1
62
63
FulfillmentElevate Health +1
64
65
Contract termsBeluga Health +30
55
25
Beluga Health · left barElevate Health · right bar

The numbers

MetricBeluga HealthElevate Health
WeighScore55.8/10058.5/100
GradeCC
Scorecard rank#430#371
SemaglutideNot disclosed$299/mo (compounded)
TirzepatideNot disclosed$399/mo (compounded)
CoverageCoverage not publishedCoverage not published
Brand-name accessCompounded onlyYes
Oral / sublingualInjection onlyInjection only
Beluga Health

Graded #430 · C

Strengths

  • Supports GLP-1 care with compounded semaglutide and tirzepatide
  • Board-certified providers and a 50-state medical infrastructure
  • LegitScript certified with SOC 2 and ISO 27001 security
  • Pharmacies follow FDA/USP standards with third-party batch testing
  • Powers many DTC brands as a turnkey telehealth backbone

Where it loses points

  • White-label B2B group, not a direct consumer-facing service
  • Offers compounded, not FDA-approved branded, GLP-1s
  • No public consumer pricing for the GLP-1 offering
  • Cited among nationwide groups tied to FDA telehealth GLP-1 scrutiny
  • Care quality varies by the consumer brand using the platform
Elevate Health

Graded #371 · C

Strengths

  • Compounded semaglutide ($299/mo, from $158/mo on 12-month) and tirzepatide ($399/mo, from $248/mo)
  • Also offers brand-name Zepbound (tirzepatide) plus NAD+, B12, and glutathione add-ons
  • All supplies included; Affirm/Klarna payment plans available
  • Full refund if you are not approved
  • 35,000+ patients served

Where it loses points

  • Month-to-month pricing is high ($299 sema / $399 tirz); the low rates require a 12-month commitment
  • Pharmacy partner and prescribing medical group not named
  • States of operation not published
  • Not LegitScript-certified (no certification displayed)
  • No standalone Terms of Service page (only Privacy, HIPAA, and a safety-information page)

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard